Speaker illustration

Doctor Lori Bash

Merck and Company, Inc., Whitehouse Station (United States of America)

The impact of worsening heart failure (WHF) status on subsequent outcomes among patients with HFrEF: History of WHF events is associated with worse subsequent outcomes regardless of extent of GDMT

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Heart failure phenotypes, diagnostics, and outcomes

Thumbnail

Comparative effectiveness of GDMT in the prevention of HF morbidity and death among patients with HFrEF in a U.S. database

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Epidemiology and outcomes

Thumbnail

Healthcare use in peripheral arterial disease without history of stroke/TIA in a large health organization

Event: ESC Congress 2016

Topic: Primary cardiovascular prevention: interventions and outcomes

Session: Cardiovascular prevention outcomes I

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb